Published on: 2025-05-21 21:26:09 Source: CZ's Dog Author: Policy & Regulation
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and Zepb... Stay informed with the latest.